The annual meeting of the American Academy of Orthopaedic Surgeons was held from March 10 to 14 in San Diego, drawing ...

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

People often visit wellness tenants including gyms three to five times a week, he said, which may lead them to patronize ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

In the 2022 semaglutide trial, participants’ blood pressure readings went back up to pretreatment levels ... But Anekwe says it’s still too early to draw conclusions from the study, which ...

they can be more choosy about where they set up a practice. PDS Health likes local shopping centers that people who live nearby visit often, preferably with a big-box draw such as Target ...

EU mid-market update: US futures stabilize after Monday rout; Oversold indicators flashing as draw-down comparisons are made; ...

As I wrote in my last note on Structure: The most famous examples of GLP-1 agonist drugs are Novo Nordisk's (NVO) semaglutide - approved ... could also open up a large market opportunity even ...